Amanda M DiNofia (Amanda DiNofia)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer medicine

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Diorio, Rawan Shraim, Regina M Myers, Edward M Behrens, Scott W Canna, Hamid Bassiri, Richard Aplenc, Chakkapong Burudpakdee, Fang Chen, Amanda M DiNofia, Saar Gill, Vanessa Gonzalez, Michele P Lambert, Allison Barz Leahy, Bruce L Levine, Robert B Lindell, Shannon L Maude, Jan Joseph Melenhorst, Haley M Newman, Jessica Perazzelli, Alix E Seif, Simon F Lacey, Carl H June, David M Barrett, Stephan A Grupp, David Trent Teachey
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Kevin Owen McNerney, Amanda M DiNofia, David T Teachey, Stephan A Grupp, Shannon L Maude
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy. Blood cancer discovery 3 (2) (2022)
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, Adam J Lamble, Jennifer Sheppard, Bonnie Yates, Alexandra Elizabeth Kovach, Brent L Wood, Michael J Borowitz, Maryalice Stetler-Stevenson, Constance M Yuan, Vinodh Pillai, Toni Foley, Perry Chung, Lee Chen, Daniel W Lee, Colleen Annesley, Amanda M DiNofia, Stephan A Grupp, Samuel John, Deepa Bhojwani, Patrick A Brown, Theodore W Laetsch, Lia Gore, Rebecca A Gardner, Susan R Rheingold, Michael A Pulsipher, Nirali N Shah
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Regina M Myers, Yimei Li, Allison Barz Leahy, David M Barrett, David Trent Teachey, Colleen Callahan, Christina C Fasano, Susan R Rheingold, Amanda M DiNofia, Lisa Wray, Richard Aplenc, Diane Baniewicz, Hongyan Liu, Pamela A Shaw, Edward Pequignot, Kelly D Getz, Jennifer L Brogdon, Andrew D Fesnak, Donald L Siegel, Megan M Davis, Chelsie Bartoszek, Simon F Lacey, Elizabeth O Hexner, Anne Chew, Gerald B Wertheim, Bruce L Levine, Carl H June, Stephan A Grupp, Shannon L Maude
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Amanda M DiNofia, Alix E Seif, Meenakshi Devidas, Yimei Li, Matthew Hall, Yuan-Shung V Huang, Viviane Cahen, Stephen P Hunger, Naomi J Winick, William L Carroll, Brian T Fisher, Eric C Larsen, Richard Aplenc
Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232. Cancer medicine 7 (1) (2017)